mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
5e-08 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
5e-08 |
mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
9e-08 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
1e-07 |
mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
1e-07 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-07 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-07 |
mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
2e-07 |
mRNA |
YM201636 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
2e-07 |
mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-07 |